Enabling commercial process oriented clone selection for a pipeline vaccine candidate through process scale down and analytical characterization

Authors

• Matthew Woodling, Merck & Co, Inc USA, USAFollow
• Sheng-ching Wang, Process Research and Development, MSD
• Zhiguo Liu, Process Research and Development, MSD
• Anthony Grippe, Process Research and Development, MSD
• Alyssa Innes, Process Research and Development, MSD

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Matthew Woodling, Sheng-ching Wang, Zhiguo Liu, Anthony Grippe, and Alyssa Innes, "Enabling commercial process oriented clone selection for a pipeline vaccine candidate through process scale down and analytical characterization" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/61